Removal of low-density lipoprotein from plasma by adsorption increases bradykinin and plasma nitric oxide levels in patients with peripheral atherosclerosis
Fibrinogen Caracas I
The effect of recombinant factor VIIa (NovoSeven™) in healthy volunteers receiving acenocoumarol to an International Normalized Ratio above 2.0
Measurement of plasma D-dimer is not useful in the prediction or diagnosis of postoperative deep vein thrombosis in patients undergoing total knee arthroplasty
Successful coronary stent implantation in a patient with primary antiphospholipid syndrome
Ischemic stroke in a young patient with protein C deficiency and prothrombin gene mutation G20210A
Two novel mutations in the prothrombin gene cause severe bleeding in a compound heterozygous patient
O1 tPA binds to its specific receptor on human vascular smooth muscle cells by a novel mechanism
O2 Protein S is expressed by cultured human vascular smooth muscle cells
O3 The anticoagulant factor protein S acts as a survival factor for cultured human vascular smooth muscle cells
O4 Endothelial cell markers and the prediction of arterial stenosis in peripheral and carotid artery disease
O5 Anti-endothelial cell antibodies are heterogeneous and distinct from anti-phospholipid antibodies
O6 A factor XIIIb subunit polymorphism is associated with factor XIII activity in patients with coronary artery disease
O7 Platelet glycoprotein IIIa polymorphism HPA 1b and fibrinogen binding
O8 Factors influencing the binding of heparin cofactor II (HCII) to normal red cells
O9 The anti-Xa activities of high and low affinity fractions of heparin
O10 Comparison of methods to study coagulation factor binding to phospholipid membranes
O11 A study on the effects of vWF on phospholipid binding of factor VIII in therapeutic concentrates using SPR technology
O12 Flow cytometric detection of prion protein within human platelets
O13 Platelet aggregation responses to human mast cell activation
O14 Dual recognition of recombinant snake venom proteins expressing specific RGD sequence motifs by the integrin αIIbβ3
O15 The perioperative injectable non-steroidal trial (POINT) and perioperative bleeding
O16 Raised factor VIII antigen concentration as a risk factor for myocardial infarction
O17 Generation of activated factor XII during cardiac surgery
P1 Detection and characterization of three novel factor XI gene mutations
P2 Increased soluble P selectin in subjects with deep vein thrombosis
P3 Racial background is a determinant of Warfarin use
P4 Untreated salvaged blood during cardiac surgery
P5 Heparin-induced thrombocytopenia
P6 Factor IX levels in post-myocardial infarction patients
P7 Effect of ketorolac and low molecular weight heparin individually and in combination on haemostasis
P8 Subclinical vitamin K deficiency in breast-fed babies aged 8–9 weeks determined by a sensitive EIA for undercarboxylated prothrombin (PIVKA-II)
P9 Inhibition of factor VII-induced Ca2+ transients in Madin-Darby canine kidney cells by an apolipoprotein BlOO-derived peptide
P10 Diagnosis of haemophilia A carriership during pregnancy utilising conformation-sensitive gel electrophoresis and DNA sequencing
P11 Evaluation of a novel ELISA screening test for detection of factor VIII inhibitory antibodies in haemophiliacs
P12 Factor VII gene polymorphisms in Pima Indians
P13 The influence of selective mutation of basic residues within the Kunitz domains on the function of TFPI
P14 Variation in inhibitor reactivity in acquired haemophilia with different concentrates
P15 Assay of vitamin K4 (phylloquinone) in plasma by HPLC
P16 Heparin modulates lipoprotein-borne vitamin K transport into cultured human osteoblasts
P17 The effects of increased atmospheric pressure (6 bar) and stress on haemostasis
A note of thanks to referees
Author index to Volume 9 1998
Cumulative Contents